Team:Chiba/Team
From 2009.igem.org
Line 22: | Line 22: | ||
'''[[Team:Chiba/Project|The Project]]''' | '''[[Team:Chiba/Project|The Project]]''' | ||
</td></tr><tr><td> | </td></tr><tr><td> | ||
- | 1, [[Team:Chiba/Project#Introduction|Introduction]] | + | '''1,''' [[Team:Chiba/Project#Introduction|Introduction]] |
</td></tr><tr><td> | </td></tr><tr><td> | ||
- | 2, [[Team:Chiba/Project#Project_Design|Project Design]] | + | '''2,''' [[Team:Chiba/Project#Project_Design|Project Design]] |
</td></tr><tr><td> | </td></tr><tr><td> | ||
- | 3, [[Team:Chiba/Project#Experiments,_Results_&_Discussion|Experiments, Results & Discussion]] | + | '''3,''' [[Team:Chiba/Project#Experiments,_Results_&_Discussion|Experiments, Results & Discussion]] |
</td></tr><tr><td> | </td></tr><tr><td> | ||
- | + | 3-1, [[Team:Chiba/Project#Making_LuxR_Mutants|Making LuxR Mutants]] | |
</td></tr><tr><td> | </td></tr><tr><td> | ||
- | + | 3-2, [[Team:Chiba/Project#Characterization_of_LuxR_Mutants|Characterization]] | |
</td></tr><tr><td> | </td></tr><tr><td> | ||
- | + | 3-3, [[Team:Chiba/Project#For_Improving_Pictures|For improving pictures]] | |
</td></tr><tr><td> | </td></tr><tr><td> | ||
- | + | 3-4, [[Team:Chiba/Project#Demonstration|Demonstration]] | |
</td></tr><tr><td> | </td></tr><tr><td> | ||
- | 4, [[Team:Chiba/Project#Conclusions|Conclusions]] | + | '''4,''' [[Team:Chiba/Project#Conclusions|Conclusions]] |
</td></tr></table> | </td></tr></table> | ||
Revision as of 18:52, 20 October 2009
E.coli Time Manager -Since 2008-
Home | The Team | Parts | Reference | Notebook | Protocols | Links | Acknowledgements | Contact |
---|
|
Who we are
What we did(Provide proper attribution for all work)
Where we're from[http://www.eng.chiba-u.ac.jp/e-index.html The Department of Applied Chemistry and Biotechnology] [http://www.chiba-u.ac.jp/e/ at Chiba University],Japan. Collaborations
SafetyFor iGEM 2009 teams are asked to detail how they approached any issues of biological safety associated with their projects. Specifically, teams should consider the following four questions:
Teams, please document any answers to these (or other) safety questions in your presentation, wiki presentation, or poster. Judges will be asked to evaluate your project, in part, on the basis of if and how you considered and addressed issues of biological safety. If any questions arise regarding iGEM and biological safety please send an email to safety AT igem.org.
|